ArticleBlood advances2023

Loss of p53 enhances the tumor-initiating potential and drug resistance of clonogenic multiple myeloma cells.

Yu-Tai Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.